Clinical Trials Logo

Canavan Disease clinical trials

View clinical trials related to Canavan Disease.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02699190 Active, not recruiting - Clinical trials for Adrenoleukodystrophy

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Start date: January 6, 2017
Phase:
Study type: Observational

Leukodystrophies, and other heritable disorders of the white matter of the brain, were previously resistant to genetic characterization, largely due to the extreme genetic heterogeneity of molecular causes. While recent work has demonstrated that whole genome sequencing (WGS), has the potential to dramatically increase diagnostic efficiency, significant questions remain around the impact on downstream clinical management approaches versus standard diagnostic approaches.

NCT ID: NCT00278707 Active, not recruiting - Clinical trials for Infantile Canavan Disease

GTA-Glyceryltriacetate for Canavan Disease

Start date: January 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether oral supplementation of glyceryl triacetate improves the clinical prognosis of Canavan Disease.